Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DAVITA INC. Director's Dealing 2014

Feb 19, 2014

30643_dirs_2014-02-19_c3d05276-2048-4b61-8303-479c85f9401a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DAVITA HEALTHCARE PARTNERS INC. (DVA)
CIK: 0000927066
Period of Report: 2014-02-14

Reporting Person: ROPER WILLIAM L (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-02-14 Common Stock S 10000 $66.3719 Disposed 4994 Direct
2014-02-18 Common Stock M 36000 $31.32 Acquired 40994 Direct
2014-02-18 Common Stock F 16989 $66.37 Disposed 24005 Direct
2014-02-18 Common Stock S 19011 $66.2178 Disposed 4994 Direct
2014-02-18 Common Stock M 36000 $41.465 Acquired 40994 Direct
2014-02-18 Common Stock F 22492 $66.37 Disposed 18502 Direct
2014-02-18 Common Stock S 13508 $66.5918 Disposed 4994 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-02-18 Stock Appreciation Right $31.32 M 36000 Disposed 2015-06-07 Common Stock (36000) Direct
2014-02-18 Stock Appreciation Right $41.465 M 36000 Disposed 2016-06-06 Common Stock (36000) Direct

Footnotes

F1: The range of prices for the sale of these shares was $66.35 - $66.39. The filer undertakes to provide staff, the issuer or a security holder full information regarding the number of shares sold at each separate price.

F2: The range of prices for the sale of these shares was $66.15 - $66.32. The filer undertakes to provide staff, the issuer or a security holder full information regarding the number of shares sold at each separate price.

F3: The range of prices for the sale of these shares was $66.32 - $66.765. The filer undertakes to provide staff, the issuer or a security holder full information regarding the number of shares sold at each separate price.

F4: Stock Appreciation Rights, pursuant to the DaVita Inc. 2002 Equity Compensation Plan, (as amended and restated, the "DaVita HealthCare Partners Inc. 2011 Incentive Award Plan," effective June 6, 2011), which vested 100% on the first anniversary of the grant date.

F5: Stock Appreciation Rights, pursuant to the DaVita HealthCare Partners Inc. 2011 Incentive Award Plan, which vested 100% on the first anniversary of the grant date.